Skip to content

Advertisement

  • Research article
  • Open Access

Measuring quality of life after intensive care using the Arabic version for Morocco of the EuroQol 5 Dimensions

  • 1,
  • 2,
  • 3,
  • 3,
  • 3,
  • 2,
  • 1, 3 and
  • 1, 2Email author
BMC Research Notes20125:56

https://doi.org/10.1186/1756-0500-5-56

©  Khoudri et al; licensee BioMed Central Ltd. 2012

  • Received: 29 October 2011
  • Accepted: 22 January 2012
  • Published:

Abstract

Background

Health-related quality of life (HRQL) is a relevant outcome measures in intensive care unit (ICU). The aim of this study was to evaluate HRQL of ICU patients 3 months after discharge using the Arabic version for Morocco of the EuroQol-5-Dimension (EQ-5D), and to examine the psychometric properties of the questionnaire.

Results

The Arabic version for Morocco of the EQ-5D was approved by the EuroQol group. A prospective cohort study was conducted after medical ICU discharge. At 3-month follow up, the EQ-5D (self classifier and EQ-VAS) was administered in consultation or by telephone. EQ-VAS varies from 0 (better HRQL) to 100 (worst HRQL). An unweighted scoring for EQ5D-index was calculated. EQ5D-index ranges from -0.59 to 1. Test-retest reliability of the EQ-5D was tested using Kappa coefficient and intraclass correlation coefficient (ICC). Criterion validity was assessed by correlating EQ-VAS and EQ5D-index with the Short Form 36 (SF-36). Construct validity was tested using simple and multiple liner regression to assess factors influencing patients'HRQL. 145 survivors answered the EQ-5D. Median EQ5D-index was 0.52 [0.20-1]. Mean EQ-VAS was 62 ± 20. Test-retest reliability was conducted in 83 patients. ICCs of EQ5D-index and EQ-VAS were 0.95 and 0.92 respectively. For EQ-5D self classifier, agreement by kappa was above 0.40. Significant correlations were noted between EQ5D-index, EQ-VAS and SF-36 (p < 0.001). In multivariate analysis, factors associated with poorer HRQL for EQ5D-index were longer ICU length of stay (β = -0.01; p = 0.017) and higher educational level (β = -0.2; p = 0.001). For EQ-VAS men were associated with better HRQL (β = 6.5; p = 0.048).

Conclusions

The Arabic version for Morocco of the EQ-5D is reliable and valid. Women, high educational level and longer ICU length of stay were associated with poorer HRQL.

Keywords

  • EQ-5D
  • Intensive care
  • Quality of life

Background

Assessing outcome after intensive care unit (ICU) care is notoriously difficult [1]. Objective study end points such as mortality are relatively easy to assess. Nevertheless, these may not be the only outcomes of interest to patients, families, and healthcare providers. If ICU treatment leads to deterioration in the quality of life, patients may be concerned that small gains in life expectancy come at too high a cost. Other outcome measures such as health-related quality of life (HRQL) are then imperative to medical evaluation [2]. HRQL is actually one of the most relevant outcome measures for patients, families, physicians and society [3].

Several scales have been used to measure the different domains of HRQL; some are generic while others are disease-specific. The generic scales attempt to capture aspects of health that are important to all patients and therefore present the advantage of comparing different groups of patients [1–4]. The EuroQol -5 Dimensions (EQ-5D) is a generic questionnaire that has been developed by an international task force aiming at creating a simple generic measure that aggregated HRQoL into a single index [5]. The EQ-5D has been already used in numerous studies and in subsets of critically ill patients [3]. The validity and reliability of the EQ have been tested in the ICU population, and it has been recommended for use in critical care medicine [6–10].

The EQ-5D is available in many major languages with cultural adaptations [11–14]. Although HRQL data are widely available on a number of western countries, few data are available in Arabic countries [15]. In North-African and Arabic countries, few HRQL studies have been published in ICUs, a Moroccan study have focused on measuring HRQL after intensive care using the Short-Form 36 (SF-36) [16]. However, to our knowledge this is the first validation study of the EQ-5D in North-African and Arabic ICUs.

This study aimed to evaluate the HRQL of a Moroccan cohort' patients alive 3 months after ICU discharge; to study its determinants and to assess the psychometric properties of the Arabic version for Morocco of the EQ-5D.

Methods

Study design, setting and subjects

This was a prospective study of Adult patients who were discharged between November 2004 and August 2005 from a medical ICU of Rabat University Hospital. The 12-bed medical ICU admits approximately 550 patients annually with an average age of 40 years. Surgery patients, coronary, neonates and burn patients are treated in specialized units. Rabat University Hospital is referral for habitants in Western-North Morocco. The protocol was approved by the Hospital Ethics Committee, and informed consent was obtained from all participants.

Inclusion criteria were adult patients (> 18 years old) with an ICU stay of more than 24 h. Patients who died during ICU stay were excluded. Patients discharged alive from ICU were asked to attend a consultation 3 months later. Survivors were then administered the EQ-5D in consultation at the 3-month follow up. If patients did not come to the follow-up consultation, a telephone contact was established for a follow-up interview. We have chosen to assess HRQL at 3 months because it seems to be ideal in the detection of only ICU-related morbidity and permits early psychological intervention if required [1]. In consultation, questionnaires were self-completed by the patients with a high education level (secondary/higher) or administrated by the same investigator if the education level is lower (none/primary). No proxy assessment was allowed. Follow-up interviews were always conducted by the same interviewer in order to ensure the EQ-5D reliability and minimize missing values.

Data collection

Background variables at admission included patient demographic data and pre-admission comorbidity classified using the Charlson Comorbidity Index (CCI) [17]: among severely ill patients, a CCI score of two or greater is associated with 1-year survival of less than 20%. Primary diagnosis, severity of disease assessed by the Acute Physiology and Chronic Health Evaluation II (APACHE II) [18], Therapeutic Intervention Scoring System (TISS) scores [19], use of mechanical ventilation and length of stay in the ICU were also recorded.

EQ-5D, translation and cultural adaptation process

The first part of the EQ-5D called "self-classifier" covers five dimensions, namely mobility, self-care, usual activities, pain/discomfort, and anxiety/depression [7, 20]. Each of these dimensions has three response options, "no problems", "moderate problems", and "extreme problems". Therefore, it classifies a respondent's health status into one of 243 (35) health states. Each health state can be assigned a weighted utility score based on different scoring systems. Due to the unavailability of Moroccan's own value set, we adopted an unweighted scoring rule based solely on answers provided by subjects to the descriptive system. The values are ranging from -0.59 to a maximum of 1 [21]. The second part of the EQ-5D questionnaire is a visual analogue scale (EQ-VAS) [22]. The EQ-VAS is a vertical, graduated (0-100 points) 20 cm 'thermometer', with 100 representing 'best imaginable health state' and 0 representing 'worst imaginable health state. The respondent rated her health on the day of the survey using both the self-classifier system and the VAS.

The Arabic version of the EQ-5D for Morocco was adapted from The United Arab Emirates Arabic version using EuroQol group guidelines and input [7]. An experienced translation consultant who is a native speaker of Moroccan Arabic and fluent in English performed forward translation. Then, a discussion was held with the project manager to produce a first consensus version of EQ-5D for Morocco. A detailed report on the review process outlining the suggested changes was submitted to the EuroQol business management. Emphasis was given to produce a clear and natural-sounding version that is acceptable to respondents in Morocco rather than a direct word by word translation. The first Moroccan consensus version of the EQ-5D was tested on five respondents irrelevant to healthcare professions. Then, a report on respondent testing was sent to the EuroQol Group business management and the Arabic version of the EQ-5D for Morocco was finalized. The translation process has taken into account the socio-cultural context and Moroccan day-life. "Usual activities" was changed to "daily activities". "Prayer" was added to the leisure dimension, "walking" was added to the mobility dimension, and "discomfort" was changed to "not to feel good physically". The Arabic version for Morocco of the EQ-5D questionnaire (Additional file 1) used was granted by the EQ-5D website (http://www.euroqol.org).

SF-36 health survey

The SF-36 is a multipurpose survey of general health status consisting of 36 items that measure eight scales or health concepts: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. Each scale is scored from 0 to 100 with a higher score reflecting a better quality of life [23]. The SF-36 was used as a reference instrument since its psychometric properties have been tested; and it was found both valid and reliable in the ICU setting [1, 24]. The Arabic version of the SF-36 has been already validated in Moroccan medical ICU population [16].

Measurement properties

The acceptability of the EQ-5D was tested by the proportion of missing or invalid responses. Responses to items of the EQ-5D self-classifier were considered invalid if more than one response level was ticked or if a tick was made in between two response levels. Responses to the EQ-VAS were considered invalid when marking was ambiguous (e.g. more than one score marked).

The test-retest reliability refers to the stability of a score derived from serial administration of a measure by the same investigator. It was determined by interviewing 83 survivors, randomly selected, on two occasions separated by 7.5 ± 1 day. The interval of a week was chosen in order to maintain health status between the two administrations. The level of agreement between responses to EQ-5D self-classifier, EQ-5D index and EQ-VAS score of the first and second interview was analysed.

Criterion validity was assessed by comparing responses to the EQ-5D with comparable subscale scores of the SF-36 obtained at the same time. This type of criterion validity is called concurrent validity [25]. The SF-36 was used as a criterion because, compared to the EQ-5D, it is a much more detailed generic measure, which has been shown to cover similar areas of HRQOL [26] and which has been successfully tested and widely used in ICUs [1, 16, 24].

Construct validity is defined as the ability of the EQ-5D to distinguish between groups that theoretically it should distinguish between. The construct validity was assessed using known-groups comparison to test for hypothesized differences with regard to sociodemographic, clinical, or ICU stay variables.

Statistical analysis

Descriptive statistics were used to characterize the study sample and their HRQL. Test-retest reliability was assessed using an Intraclass Correlation Coefficient (ICC) for EQ-VAS and EQ-5D index. An ICC above 0.70 is considered to be acceptable [27]. Additionally, the degree of agreement for the EQ-5D self-classifier was evaluated by kappa statistics, which greater than 0.75 indicates excellent agreement, below 0.40 poor, and between 0.40 and 0.75 fair-to-good [28]. For criterion validity with respect to the items of the EQ-5D selfclassifier, we analysed whether the response levels of each item were associated with different comparable SF-36 scores using t test. For the EQ-VAS score and EQ-5D index, Pearson and Spearman correlation coefficients with the SF- 36 subscales were respectively calculated. Factors influencing HRQL were studied in univariate analysis using simple linear regression model. Variables with p < 0.20 were then included in a multiple linear regression model. The level of significance was 0.05. All statistical analyses were carried out using SPSS version 13.0 (SPSS; Chicago, IL, USA).

Results

During the study period a total of 311 patients were admitted to the ICU, and 132 were excluded because of death in ICU (n = 92), discharge within 24 h of admission (n = 13), or age under 18 years (n = 27). The remaining 179 patients were discharge alive from ICU. Four patients died before the 3-month follow up, and 27 were lost to follow up. At follow up, 3 survivors were excluded (delirious or unable to understand Arabic), 84 (58%) were interviewed in consultation and 61 (42%) were interviewed by telephone. Thus, 145 survivors completed the EQ-5D (Figure 1). The sociodemographic and clinical characteristics of the study patients (n = 145) are shown in Table 1.
Figure 1
Figure 1

Patients included and excluded from the study.

Table 1

Sociodemographic and clinical characteristics of study patients (n = 145)

Characteristics

Age, years; mean ± SD

38.2 ± 17

Gender male; n(%)

79 (54)

Marital status ; n(%)

   Single

75 (52)

   Married

70 (48)

Minimum educational level ; n(%)

   None

54 (37)

   Primary

41 (27)

   Secondary/higher

50 (36)

ICU length of stay, days; mediane [IQR]

6 [3–10]

CCI , n (%)

   0

92 (64)

   1

37 (25)

   ≥2

16 (11)

APACHE II, first 24 hrs; mean ± SD

14.1 ± 6

TISS, first 24 hrs; mean ± SD

20 ± 6

Mechanical ventilation ; n(%)

35 (22)

ICU admitting diagnostic categories ; n(%)

   Sepsis

36 (24)

   Intoxication

33 (23)

   Neurologic

23 (16)

   Respiratory

21 (15)

   Metabolic

14 (9)

   Cardiovascular

11 (8)

   Miscellaneous

7 (5)

ICU, intensive care unit; CCI, Charlson Comorbidity Index; APACHE II, Acute Physiology and Chronic Health Evaluation II; TISS, Therapeutic Intervention Scoring System

In the total sample, responses to the EQ-5D self classifier are summarized in Table 2. The median of EQ-5D index was 0.52 [0.20-1]. Mean EQ-VAS was 62 ± 20 and ranged from 20 to 100. There were no missing data or invalid responses in the EQ-5D self classifier and EQ-VAS.
Table 2

Score distributions of the EQ-5D self classifier in ICU patients

EQ-5D dimensions

Responses;n(%)

 

No problems

Moderate problems

Extreme problems

Mobility

80 (55)

46 (32)

19 (13)

Self-care

115 (79)

20 (14)

10 (7)

Usual activities

77 (53)

40 (28)

28 (19)

Pain/discomfort

74 (51)

43 (30)

28 (19)

Anxiety/depression

74 (51)

48 (33)

23 (16)

Concerning the results of test-retest reliability in the 83 survivors, the ICCs of the EQ-5D index and EQ-VAS at 7.5 ± 1 day interval were 0.95 and 0.92 respectively exceeding then 0.70. For EQ-5D self classifier, agreement by kappa was excellent in pain/discomfort dimension and fair-to-good in the other dimensions (Table 3).
Table 3

Test-retest reliability of EQ-5D

 

Kappa-statistic

ICC

EQ-5D self classifier

Mobility

0.73

 

Self-care

0.49

 

Usual activities

0.66

 

Pain/discomfort

0.92

 

Anxiety/depression

0.72

 

EQ-5D index

 

0.95

EQ-VAS

 

0.92

ICC, Intraclass correlation coefficient; VAS, visual analogue scale

ICC > 0.70 is considered acceptable. Kappa statistics > 0.75 indicates excellent agreement, < 0.40 poor, and between 0.40 and 0.75 fair-to-good

Concerning criterion validity, Table 4 shows the mean scores of SF-36 subscales according to their level of response to comparable EQ-5D items. For all EQ-5D items, mean SF-36 scores were ordered appropriately and were significantly different between the groups; as patients reporting moderate or extreme problems for EQ-5D dimensions at follow up generally had lower mean SF-36 scores than those without such problems. Significant correlations were also noted between EQ5D-index, EQ-VAS and SF-36 subscales (Table 4).
Table 4

Criterion validity of EQ-5D with regard to SF-36 subscales

 

SF-36 subscales

 

GH

PF

RP

RE

SF

BP

VT

MH

Mobility

   No problems

71 ± 15

96 ± 6

100 ± 0

80 ± 40

88 ± 22

89 ± 17

64 ± 9

74 ± 14

   Moderate/extreme

46 ± 15

54 ± 27

38 ± 48

44 ± 50

47 ± 32

50 ± 32

48 ± 14

66 ± 17

   P

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

0.011

Self-care

   No problems

63 ± 18

85 ± 18

80 ± 39

72 ± 44

79 ± 25

76 ± 28

60 ± 13

72 ± 15

   Moderate/extreme

41 ± 14

37 ± 31

23 ± 42

23 ± 42

23 ± 27

44 ± 13

43 ± 13

64 ± 21

   P

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

0.031

Usual activities

   No problems

72 ± 12

95 ± 6

96 ± 17

84 ± 36

92 ± 14

86 ± 22

65 ± 8

76 ± 11

   Moderate/extreme

42 ± 12

52 ± 28

36 ± 48

36 ± 48

39 ± 28

50 ± 32

45 ± 12

63 ± 18

   P

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

Pain/discomfort

        

   No problems

68 ± 17

88 ± 20

91 ± 27

75 ± 43

83 ± 30

96 ± 8

62 ± 13

73 ± 17

   Moderate/extreme

48 ± 17

61 ± 30

45 ± 50

48 ± 50

51 ± 31

42 ± 23

50 ± 14

67 ± 16

   P

< 0.001

< 0.001

< 0.001

0.001

< 0.001

< 0.001

< 0.001

0.038

Anxiety/depression

   No problems

68 ± 14

83 ± 24

82 ± 38

92 ± 27

86 ± 23

83 ± 25

64 ± 9

82 ± 8

   Moderate/extreme

48 ± 19

66 ± 31

53 ± 50

30 ± 46

47 ± 33

54 ± 32

47 ± 13

57 ± 13

   P

< 0.001

0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

EQ-5D index

0.79*

0.82*

0.68*

0.64*

0.87*

0.75*

0.76*

0.53*

EQ-VAS

0.62†

0.53†

0.48†

0.62†

0.70†

0.47†

0.65†

0.42†

* Spearman correlation coefficients (p < 0.001)

† Pearson correlation coefficients (p < 0.001)

SF-36, Short Form 36; GH, General Health; PF, Physical Functioning; RP, Role Physical; RE, Role Emotional; SF, social Functioning; BP, bodily pain; VT, vitality; MH, Mental Health

Construct validity of the EQ-5D was confirmed since differences in EQ-5D index and EQ-VAS scores were found between groups of patients (Table 5). Concerning EQ-5D index, in univariate analysis, factors associated with poorer HRQL at follow up were elder age (β = -0.01; p < 0.001), married status (β = -0.3; p < 0.001), higher educational level (β = -0.2; p = 0.010), and longer ICU length of stay (β = -0.01; p = 0.049). In multivariate analysis, longer ICU length of stay and higher educational level were both associated with poorer HRQL (β = -0.01; p = 0.017 and β = -0.2; p = 0.001 respectively). Concerning EQ-VAS, in univariate analysis, factors associated with poorer HRQL at follow up were elder age (β = -0.4; p = 0.001) and married status (β = -13.3; p < 0.001). In multivariate analysis, men were associated with better HRQL (β = 6.5; p = 0.048).
Table 5

Construct validity of EQ-5D

 

EQ-VAS

EQ-5D index

 

Univariate

analysis

Multivariate

analysis

Univariate

analysis

Multivariate

analysis

 

ß(SE)

p

ß(SE)

p

ß(SE)

p

ß(SE)

p

Age

-0.4(0.1)

0.001

-0.06(0.1)

0.714

-0.01(0.003)

< 0.001

-0.004(0.003)

0.286

Gender

   Female

0

 

0

 

0

   

   Male

5.6(3.4)

0.106

6.5(3.5)

0.048

0.02(0.1)

0.777

  

Marital status

   Single

0

 

0

 

0

 

0

 

   Married

-13.3(3.2)

< 0.001

-8.7(5.1)

0.090

-0.3(0.08)

< 0.001

-0.1(0.1)

0.319

Educational level

   None

0

 

0

 

0

 

0

 

   Primary

-3.9(4.5)

0.384

-6.8(4.5)

0.133

-0.03(0.1)

0.370

-0.02(0.09)

0.78

   Secondary/higher

-7.5(4.3)

0.082

-2.6(4.3)

0.535

-0.2(0.1)

0.010

-0.2(0.08)

0.001

CCI

   0

0

   

0

 

0

 

   ≥1

-3.8(4.5)

0.396

  

-0.1(0.1)

0.164

0.04(0.09)

0.665

Mechanical ventilation

   No

0

   

0

   

   Yes

2.6(4.0)

0.512

  

0.00(0.1)

0.997

  

APACHE II

-0.01(0.3)

0.971

  

-0.006(0.01)

0.570

  

TISS

-0.3(0.3)

0.214

  

-0.01(0.008)

0.122

-0.01(0.01)

0.085

Length of stay

-0.02(0.2)

0.897

  

-0.01(0.006)

0.049

-0.01(0.005)

0.017

VAS, visual analogue scale; SE, standard error; CCI, Charlson Comorbidity Index; APACHE II, Acute Physiology and Chronic Health Evaluation II; TISS, Therapeutic Intervention Scoring System

Discussion

This paper reports the results of the first North-African prospective study concerning the HRQL of ICU patients using the EQ-5D Arabic version. This study provided evidence that the Arabic version of the EQ-5D for Morocco has a good acceptability reliability and validity. Thus, it can be considered as a valid measure of Moroccan patients' health status.

Previous studies have found that the HRQL of patients surviving ICU tends to be significantly poorer than that of samples of the general population [29, 30]. Our results showed a relatively high level of HRQL among survivors 3 months after ICU discharge (mean EQ-VAS 62 ± 20 and median EQ-5D index 0.52 [0.20-1]). Other reports using different tools agree with these results [10, 16, 31]. In our study, moderate to extreme problems in pain/discomfort were reported by 49% of the responders, 47% and 45% of patients reported moderate to extreme problems with usual activities and mobility respectively. But only 21% reported the same level of problems in self-care. Elsewhere, anxiety/depression was the only dimension causing moderate to extreme problems in more than 50% of the patients. These findings are similar to that of Granja et al. [10] using the EQ-5D 6 months after ICU discharge where pain/discomfort and anxiety/depression were the most frequently reported problems. Other studies using different tools [29, 31] reported also the same findings in ICUs where emotional problems and anxiety/depression were the most frequent one. Concerning EQ-5D index, in order to eliminate the possible influence that social preferences may have on the score, an unweighted scoring rule was developed based solely on answers provided by subjects to the descriptive system [21]. This unweighted scoring strategy was used in our study because it simply combines the answers provided by the subjects to each of item of the questionnaire.

The EQ-5D was well accepted and understood by ICU patients at follow-up, as shown by the lack of missing and invalid responses. Furthermore, EQ-5D is known to be a simple and short questionnaire easily understood and answered by the patient; these can make it an instrument of choice in ICU patients [10].

Because comparative studies require instruments in several languages, cross-cultural adaptation of HRQL questionnaires should be entertained carefully [32]. Although EQ-5D has been translated into more than 50 different languages including classic Arabic, few publications have described the process of cross-cultural adaptation and validation in detail and none is available in the North-African countries [15]. Before being used in a socio-cultural and specific setting, the EQ-5D needs to demonstrate satisfactory psychometric properties because of its brevity and because of information for each dimension being derived from only one item [13]. The EQ-5D demonstrated good test-retest reliability. The ICC was excellent in our study (0.95 and 0.92 for the EQ-5D index and EQ-VAS respectively). Kappa-statistics were satisfactory in overall the five EQ-5D dimensions (0.66-0.92). Several other validated EQ-5D versions from foreign countries have also demonstrated good reliability with comparable results [11, 12, 14].

The SF-36 is one of the most widely used generic health status measure that can be considered as a "Gold Standard" in ICU settings [1, 24]. Its psychometric properties have already been proved in a Moroccan medical ICU [16]. Comparison of EQ-5D response with subscale scores of SF-36 showed excellent criterion validity, the EQ-5D index and EQ-VAS correlated well with the eight SF-36 health domains. So was found in a German study comparing EQ-5D and SF-36 in cardiac rehabilitation [11] and another one in patients with inflammatory bowel disease [33].

The HRQL of ICU patients has been investigated at various follow-up times. Assessment of HRQL at 90 days may be ideal for the detection of ICU related sequelae, because more time passes the larger are the effects of increasing age and possibly new comorbidities on HRQL [34]. The construct validity of the EQ-5D was confirmed in our study. In multivariate analysis, linear regression model indicated that women had poorer HRQL (EQ-VAS), a fact that has been already reported in the literature where women report worse health than men in ICUs [16]. Surprisingly, we found that ICU patients with high education levels had poorer HRQL contrary to what has been reported in the literature [10]. The differences between these findings and ours can be explained by cultural specificities, concerning values, perceptions, and expectations regarding health care [35]. Patients with a high level of culture and education may be more emotionally and/or physically demanding; while those with low education levels because the lack of culture, their only religious beliefs make them consider their health status as God's will and may express then better HRQL. Moreover, poorer HRQL related with high education level can be also explained by the fact that questionnaires were self-completed by this category of patients, this may have facilitated the fully expression of health status assessment. ICU patients with less education level may have been intimidated by the presence of the investigator while completing questionnaires. Longer ICU length of stay was also associated with poorer HRQL, a fact that is common in earlier studies [10, 16]. In our study, age was not found to be related to HRQL. In fact, the impact of age on HRQL is controversial in ICUs: impairment of HRQL with elderly has been previously reported [10] whereas other studies showed no influence of age [36].

There are some limitations in the study. First, the EQ-5D is a self-administered questionnaire, but the problem of the low literacy in Morocco yielded to a self-administration or administration by the same investigator following the level of education of the patients. This may introduce bias in the results; however no consensus is available concerning the problem of administrating questionnaires in low literacy populations [37]. Second, a large number of the patients were excluded from the study; this may have introduced bias into the results. Third, the EQ-5D was administered 3 months after ICU discharge; HRQL may then vary over time.

Conclusions

We conclude that the Morrocan Arabic EQ-5D has good acceptability and validity in measuring health status after intensive care in Morocco. Three months after ICU discharge, women and survivors with higher educational level and longer ICU length of stay expressed poorer HRQL. In our context, the use of the EQ-5D can be recommended in order to provide a better picture of the HRQL among ICU patients. These data provide a basis for further studies of the EQ-5D in Morocco.

Abbreviations

APACHE II: 

Acute Physiology and Chronic Health Evaluation II

CCI: 

Charlson comorbidity index

EQ-5D: 

EuroQol-5-Dimension

HRQL: 

Health-related quality of life

ICC: 

Intraclass correlation coefficient

ICU: 

Intensive care unit

SF-36: 

Short form 36

TISS: 

Therapeutic intervention scoring system

VAS: 

Visual analogue scale.

Declarations

Acknowledgements

We gratefully acknowledge Dr M. Kettani, Dr L. Oualili, and Dr H. Elkarni for their help and support with this study. We would also like to thank Mr and Mrs Khoudri for their financial support, and the nursing staff of the medical intensive care unit.

Authors’ Affiliations

(1)
Faculty of Medicine, Laboratory of Biostatistics Clinical and Epidemiological Research, Rabat, Morocco
(2)
Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco
(3)
Medical Intensive Care Unit, Ibn Sina University Hospital, Rabat, Morocco

References

  1. Eddleston JM, White P, Guthrie E: Survival, morbidity, and quality of life after discharge from intensive care. Crit Care Med. 2000, 28: 2293-2299.PubMedView ArticleGoogle Scholar
  2. Graf J, Koch M, Dujardin R, Kersten A, Janssens U: Health-related quality of life before, 1 month after, and 9 months after intensive care in medical cardiovascular and pulmonary patients. Crit Care Med. 2003, 31: 2163-2169. 10.1097/01.CCM.0000079607.87009.3A.PubMedView ArticleGoogle Scholar
  3. Capuzzo M, Bertacchini S, Davanzo E, Felisatti G, Paparella L, Tadini L, Alvisi R: Health-related quality of life before planned admission to intensive care: memory over three and 6 months. Health Qual Life Outcomes. 2010, 8: 103-10.1186/1477-7525-8-103.PubMedPubMed CentralView ArticleGoogle Scholar
  4. Sabbah I, Drouby N, Sabbah S, Retel-Rude N, Mercier M: Quality of Life in rural and urban populations in Lebanon using SF-36 Health Survey. Health Qual Life Outcomes. 2003, 1: 30-10.1186/1477-7525-1-30.PubMedPubMed CentralView ArticleGoogle Scholar
  5. Group EuroQol: EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16: 199-208.View ArticleGoogle Scholar
  6. Needham DM, Dowdy DW, Mendez-Tellez PA, Herridge MS, Pronovost PJ: Studying outcomes of intensive care unit survivors. Measuring exposures and outcomes. Intensive Care Med. 2005, 31: 1153-1160. 10.1007/s00134-005-2656-7.PubMedView ArticleGoogle Scholar
  7. Brooks R, with the EuroQol Group: EuroQol: the current state of play. Health Policy. 1996, 37: 53-72. 10.1016/0168-8510(96)00822-6.PubMedView ArticleGoogle Scholar
  8. Badia X, Diaz-Prieto A, Gorriz MT, Herdman M, Torrado H, Farrero E, Cavanilles JM: Using the EuroQol-5D to measure changes in quality of life 12 months after discharge from an intensive care unit. Intensive Care Med. 2001, 27: 1901-1907. 10.1007/s00134-001-1137-x.PubMedView ArticleGoogle Scholar
  9. Garcia Lizana F, Peres Bota D, De Cubber M, Vincent J-L: Long-term outcome in ICU patients: what about quality of life?. Intensive Care Med. 2003, 29: 1286-1293. 10.1007/s00134-003-1875-z.PubMedView ArticleGoogle Scholar
  10. Granja C, Teixeira-Pinto A, Costa-Pereira A: Quality of life after intensive care-evaluation with EQ-5D questionnaire. Intensive Care Med. 2002, 28: 898-907. 10.1007/s00134-002-1345-z.PubMedView ArticleGoogle Scholar
  11. Schweikert B, Hahmann H, Leidl R: Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart. 2006, 92: 62-67. 10.1136/hrt.2004.052787.PubMedPubMed CentralView ArticleGoogle Scholar
  12. Kim MH, Cho YS, Uhm WS, Kim S, Bae SC: Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res. 2005, 14: 1401-1406. 10.1007/s11136-004-5681-z.PubMedView ArticleGoogle Scholar
  13. Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J: Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res. 2003, 12: 87-92. 10.1023/A:1022063721237.PubMedView ArticleGoogle Scholar
  14. Lang HC, Chuang L, Shun SC, Hsieh CL, Lan CF: Validation of EQ-5D in patients with cervical cancer in Taiwan. Support Care Cancer. 2010, 18: 1279-1286. 10.1007/s00520-009-0745-9.PubMedView ArticleGoogle Scholar
  15. Aburuz S, Bulatova N, Twalbeh M, Gazawi M: The validity and reliability of the Arabic version of the EQ-5D: a study from Jordan. Ann Saudi Med. 2009, 29: 304-308. 10.4103/0256-4947.55313.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Khoudri I, Ali Zeggwagh A, Abidi K, Madani N, Abouqal R: Measurement properties of the Short Form 36 and health-related quality of life after intensive care in Morocco. Acta Anaesthesiol Scand. 2007, 51: 189-197. 10.1111/j.1399-6576.2006.01225.x.PubMedView ArticleGoogle Scholar
  17. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016/0021-9681(87)90171-8.PubMedView ArticleGoogle Scholar
  18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med. 1985, 13: 818-829. 10.1097/00003246-198510000-00009.PubMedView ArticleGoogle Scholar
  19. Keene AR, Cullen DJ: Therapeutic intervention scoring system: update 1983. Crit Care Med. 1983, 11: 1-3. 10.1097/00003246-198301000-00001.PubMedView ArticleGoogle Scholar
  20. Kind P: The EuroQol instrument: an index of health-related quality of life. Quality of life and pharmacoeconomics in clinical trials. Edited by: Spiker B. 1996, Philadelphia: Lippincott-Raven Publishers, 191-201.Google Scholar
  21. Prieto L, Sacristán JA: What is the value of social values? The uselessness of assessing health-related quality of life through preference measures. BMC Med Res Methodol. 2004, 4: 10-10.1186/1471-2288-4-10.PubMedPubMed CentralView ArticleGoogle Scholar
  22. Rabin R, de Charro F: EQ-5D: A measure of health status from the EuroQol Group. Ann Med. 2001, 33: 337-343. 10.3109/07853890109002087.PubMedView ArticleGoogle Scholar
  23. Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483. 10.1097/00005650-199206000-00002.PubMedView ArticleGoogle Scholar
  24. Chrispin PS, Scotton H, Rogers J, Lloyd D, Ridley SA: Short Form 36 in the intensive care unit: assessment of acceptability, reliability and validity of the questionnaire. Anaesthesia. 1997, 52: 15-23. 10.1111/j.1365-2044.1997.015-az014.x.PubMedView ArticleGoogle Scholar
  25. Bowling A: Measuring disease. 1995, Buckingham: Open University PressGoogle Scholar
  26. Dorman PJ, Dennis M, Sandercock P: How do scores on the EuroQol relate to scores on the SF-36 after stroke?. Stroke. 1999, 30: 2146-2151. 10.1161/01.STR.30.10.2146.PubMedView ArticleGoogle Scholar
  27. Shrout PE, Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979, 86: 420-428.PubMedView ArticleGoogle Scholar
  28. Fleiss JL: Statistical Methods for Rates and Proportions. 1981, New York: WileyGoogle Scholar
  29. Brooks R, Kerridge R, Hillman K, Bauman A, Daffurn K: Quality of life outcomes after intensive care. Comparisons with a community group. Intensive Care Med. 1997, 23: 581-586. 10.1007/s001340050376.PubMedView ArticleGoogle Scholar
  30. Ridley SA, Chrispin PS, Scotton H, Rogers J, Lloyd D: Changes in quality of life after intensive care: comparison with normal data. Anesthesia. 1997, 52: 195-202. 10.1111/j.1365-2044.1997.073-az0068.x.View ArticleGoogle Scholar
  31. Sznajder M, Aegerter P, Launois R, Merliere Y, Guidet B, CubRea: A cost-effectiveness analysis of stays in intensive care units. Intensive Care Med. 2001, 27: 146-153. 10.1007/s001340000760.PubMedView ArticleGoogle Scholar
  32. Scientific Advisory Committee of the Medical Outcomes Trust: Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002, 11: 193-205. 10.1023/A:1015291021312.View ArticleGoogle Scholar
  33. König HH, Ulshöfer A, Gregor M, von Tirpitz C, Reinshagen M, Adler G, Leidl R: Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002, 14: 1205-1215. 10.1097/00042737-200211000-00008.PubMedView ArticleGoogle Scholar
  34. Capuzzo M, Moreno RP, Jordan B, Bauer P, Alvisi R, Metnitz PG: Predictors of early recovery of health status after intensive care. Intensive Care Med. 2006, 32: 1832-1838. 10.1007/s00134-006-0307-2.PubMedView ArticleGoogle Scholar
  35. Damghi N, Khoudri I, Oualili L, Abidi K, Madani N, Zeggwagh AA, Abouqal R: Measuring the satisfaction of intensive care unit patient families in Morocco: a regression tree analysis. Crit Care Med. 2008, 36: 2084-2091. 10.1097/CCM.0b013e31817c104e.PubMedView ArticleGoogle Scholar
  36. Chelluri L, Pinsky MR, Donahoe MP, Grenvik A: Long-term outcome of critically ill elderly patients requiring intensive care. JAMA. 1993, 269: 3119-3123. 10.1001/jama.1993.03500240063027.PubMedView ArticleGoogle Scholar
  37. Hahn EA, Cella D: Health outcomes assessment in vulnerable populations: measurement challenges and recommendations. Arch Phys Med Rehabil. 2003, 84: 35-42.View ArticleGoogle Scholar

Copyright

© Khoudri et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

BMC Research Notes

ISSN: 1756-0500

Contact us